BioSpace News Archive

Policy

Trump Administration’s ‘Operation Warp Speed’ Zeroes in on 14 Possible COVID-19 Vaccines

The Hill reports that the six or eight selected will go into clinical trials, where “health experts are looking to weed out faulty candidates and come out with three or four vaccines that clear final testing to be used by early 2021.”

May 4, 2020
·
3 min read
·
Mark Terry
Business

Sequana Medical Announces the Appointment of Dr. Oliver Gödje as Chief Medical Officer

Sequana Medical NV, an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, announces the appointment of Oliver Gödje, MD, PhD, as Chief Medical Officer, with immediate effect.

May 4, 2020
·
5 min read
Drug Development

Targovax Releases Update for Mesothelioma Trial Combining ONCOS-102 and Chemotherapy

Progression free survival at the 9-month follow-up is tracking in line with previously published data

May 4, 2020
·
2 min read
Nanoform Awarded GMP Certification

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, has been awarded a Good Manufacturing Practices certification by the Finnish Medicines Agency, FIMEA.

May 4, 2020
·
2 min read
Study Finds Noninvasive, Continuous Masimo PVi® Monitoring More Valuable Than Central Venous Pressure Measurement for Guiding Fluid Management During Surgery

Masimo announced the findings of a study published in the Journal of Anesthesiology and Reanimation Specialists’ Society in which researchers compared two methods of intraoperative fluid management during orthopedic spinal surgery, including Masimo PVi®.

May 4, 2020
·
8 min read
Business

SciBase and Advanced Dermatology and Cosmetic Surgery Group Partner to Advance Skin Cancer Detection in US’ Largest Dermatology Network

SciBase announced, on “Melanoma Monday”, that they have entered into a collaboration agreement with Advanced Dermatology and Cosmetic Surgery - the premier dermatology network in the US with over 150 practices.

May 4, 2020
·
4 min read
Deals

Median Technologies: Liquidity Contract Transfer to Louis Capital Markets

Median Technologies is announcing that on March 30, 2020, it concluded a new liquidity contract with the Company Louis Capital Markets in accordance with the Amafi charter.

May 4, 2020
·
3 min read
Pharm Country

Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals

Beyond expectations, a single injection of DNA in mice induced antibodies that block the infection of cultured human cells by SARS-CoV-2

May 4, 2020
·
6 min read
Pharm Country

BrainStorm Presents New Data Highlighting NurOwn® Immunomodulation in Neurology

BrainStorm Cell Therapeutics Inc. announced that new data highlighting the immunomodulatory effects of NurOwn® on B and T regulatory function appeared in an online supplement to Neurology.

May 4, 2020
·
5 min read
Business

Seoul Viosys Reports First Quarter 2020 Results

Seoul Viosys Co., Ltd., a leading global innovator of short wavelength LED products and technology, announced KRW 87 billion for consolidated revenue for the first quarter and operating profit of KRW 2.7 billion.

May 4, 2020
·
3 min read